Skip to content
The Chat Archive
gpt-4-1106-preview· OpenAI Arena Human Preference 55K

European girl named Emese born at 12.11.2004 had her first glasses prescription at…

  1. User

    European girl named Emese born at 12.11.2004 had her first glasses prescription at 04.10.2021 with OD SPH 0.0D CYL -0.5Dx180 OS SPH -0.25D CYL -0.25Dx160. Her second precription at 04.04.2022 was OD SPH 0.0D CYL -0.75Dx180 OS SPH -0.5D CYL -0.25Dx160. Her next prescription at 11.10.2022 no progression but overcorrected by SPH -0.5D both eyes. Her last prescription at 06.06.2023 no progression but overcorrected by SPH -0.75D both eyes. She will be in school for the next 2.5 years, and using computer and smartphone 10+ hours. She going out just for school. What is her predicted myopia progression by the next years at 20, 25, 30 with diopters. In details with examples in diopters. What is the impact of overcorrection? What if overcorrection maintened the same? No problem or sympoms by overcorrection. With example prescriptions in diopter

  2. Assistant

    Predicting the exact progression of myopia (nearsightedness) in an individual is challenging because it can depend on various factors, including genetics, environmental influences, and lifestyle habits. However, I can provide some general information based on Emese's history and current trends.

    Given Emese's prescription history, it seems that she has mild myopia with some astigmatism. Her myopia has not significantly progressed between the ages of 16 and 18 based on the prescriptions provided. However, this does not guarantee that it will remain stable in the future.

    Here's a general outlook:

    • At age 20: If her lifestyle remains the same with intensive near work and limited time outdoors, her myopia could potentially progress. Typically, myopia progression slows down significantly or stops in the late teens to early twenties. If there is progression, it might be a small increment, such as an additional -0.25 to -0.50 diopters.

    • At age 25: By this age, her eyeball growth should have stabilized, and significant progression of myopia is less common unless there are other underlying health issues or her visual environment changes drastically.

    • At age 30: It is less likely for myopia to progress after the mid-20s unless due to pathological myopia or other health conditions. Most individuals experience stability in their prescription.

    Overcorrection, which means prescribing glasses that are too strong for the distance vision, can have several potential impacts:

    1. Visual Comfort: Overcorrection might cause discomfort, headaches, or eye strain because the eyes are constantly working to adjust to the incorrect prescription.

    2. Binocular Vision: Overcorrection can affect the balance between the two eyes and may impact binocular vision and depth perception.

    3. Accommodation: Over time, overcorrection can affect the eye's ability to accommodate (focus on objects at different distances). This could potentially lead to eye strain during near tasks.

    4. Myopia Progression: There is some debate among eye care professionals about the impact of overcorrection on myopia progression. Some studies suggest that overcorrection might contribute to further myopia progression, but the evidence is not conclusive.

    If Emese continues to be overcorrected by -0.75D in both eyes without any symptoms, it is possible that her visual system has adapted to this overcorrection. However, it is generally advisable to use the correct prescription to ensure visual comfort and optimal visual performance.

    As for maintaining the same level of overcorrection, if Emese is not experiencing any symptoms now, she might not experience any in the near future. However, it is important to monitor her visual comfort and eye health closely with regular eye examinations.

    Example prescriptions if her myopia were to progress could look like this:

    • At age 20: OD SPH -0.25D CYL -0.75Dx180, OS SPH -0.75D CYL -0.25Dx160 (assuming a progression of -0.25D)
    • At age 25: OD SPH -0.25D CYL -0.75Dx180, OS SPH -0.75D CYL -0.25Dx160 (assuming no further progression)
    • At age 30: OD SPH -0.25D CYL -0.75Dx180, OS SPH -0.75D CYL -0.25Dx160 (assuming no further progression)

    Given the variability in individual cases, these predictions are highly speculative. Regular eye exams with an optometrist or ophthalmologist are essential to monitor Emese's eye health and adjust her prescription as needed.

Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.